Safety profiles of Tripterygium wilfordii Hook F: a systematic review and meta-analysis

Safety profiles of Tripterygium wilfordii Hook F: a systematic review and meta-analysis

Objective: Tripterygium wilfordii Hook F (TwHF) is a widely used and effective treatment for inflammatory diseases. There have been concerns about its toxicity but no adequate synthesis of the evidence for adverse events (AEs). We aimed to undertake a clinically informative, systematic safety profil...

Full description

Bibliographic Details
Main Authors:	Chi Zhang, Ping-Ping Sun, Hong-Tao Guo, Yan Liu, Jian Li, Xiao-Juan He, Aiping Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-11-01
Series:	Frontiers in Pharmacology
Subjects:	Safety Meta-analysis Systematic review adverse events Tripterygium wilfordii Hook F
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00402/full

Similar Items

Adverse Events Associated With Treatment of Tripterygium wilfordii Hook F: A Quantitative Evidence Synthesis
by: Yi Ru, et al.
Published: (2019-11-01)

Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases
by: Xue Tong, et al.
Published: (2022-03-01)

Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis
by: Liu Liu, et al.
Published: (2018-08-01)

Efficacy and Safety of Tripterygium wilfordii Hook F Versus Acitretin in Moderate to Severe Psoriasis Vulgaris: A Randomized Clinical Trial
by: Chao Wu, et al.
Published: (2015-01-01)

The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review
by: Peng Liu, et al.
Published: (2021-09-01)

The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Ying-Yan Zhou, et al.
Published: (2018-04-01)

Tripterygium wilfordii Hook. F. and Its Extracts for Psoriasis: Efficacy and Mechanism
by: Wang Y, et al.
Published: (2023-12-01)

A novel strategy to enhance terpenoids production using cambial meristematic cells of Tripterygium wilfordii Hook. f.
by: Yadi Song, et al.
Published: (2019-11-01)

A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
by: Shao-Ru Chen, et al.
Published: (2018-02-01)

Tripterygium wilfordii Hook.f. ameliorates paraquat-induced lung injury by reducing oxidative stress and ferroptosis via Nrf2/HO-1 pathway
by: Cong-Ying Song, et al.
Published: (2023-03-01)

Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study
by: Yang-zhong Zhou, et al.
Published: (2018-04-01)

Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis
by: Yehui Li, et al.
Published: (2021-06-01)

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria
by: Yuanyuan Guo, et al.
Published: (2021-01-01)

The Combination of Low-Temperature Plasma and <i>Tripterygium wilfordii Hook F</i> on Ameliorating Imiquimod-Induced Psoriasiform Dermatitis in Mice
by: Song Zhang, et al.
Published: (2021-12-01)

The complete chloroplast genome of Tripterygium wilfordii Hook. f. (Celastraceae)
by: Yuan Zhong, et al.
Published: (2022-09-01)

A comprehensive review of Tripterygium wilfordii hook. f. in the treatment of rheumatic and autoimmune diseases: Bioactive compounds, mechanisms of action, and future directions
by: Yu Shan, et al.
Published: (2023-11-01)

Qingluo Tongbi Formula Alleviates Hepatotoxicity Induced by Tripterygium wilfordii Hook. F. by Regulating Excessive Mitophagy Through the PERK-ATF4 Pathway
by: Linluo Zhang, et al.
Published: (2022-07-01)

The effects of Tripterygium wilfordii Hook F on renal outcomes in type 2 diabetic kidney disease patients with severe proteinuria: a single-center cohort study
by: Yaqi Cheng, et al.
Published: (2024-12-01)

Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
by: Hongyun Wang, et al.
Published: (2023-08-01)

Network pharmacology- and molecular docking-based approach for predicting key targets and the potential mechanism of Tripterygium wilfordii Hook F for the treatment of acute lymphoblastic leukaemia
by: Xi Li, et al.
Published: (2022-12-01)

Immunosuppressive Sesquiterpene Pyridine Alkaloids from <i>Tripterygium wilfordii</i> Hook. f.
by: Yadan Wang, et al.
Published: (2022-10-01)

Screening of major hepatotoxic components of Tripterygium wilfordii based on hepatotoxic injury patterns
by: Meng Li, et al.
Published: (2023-01-01)

New 18(4→3)-Abeo-Abietanoids from Tripterygium wilfordii
by: Lin Ni, et al.
Published: (2018-09-01)

Mechanism of Tripterygium wilfordii Hook.F.- Trichosanthes kirilowii Maxim decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking
by: Lingfei Lu, et al.
Published: (2022-10-01)

A network pharmacology study on the Tripteryguim wilfordii Hook for treatment of Crohn’s disease
by: Jing Zhang, et al.
Published: (2020-03-01)

Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking
by: Jing Zhang, et al.
Published: (2021-01-01)

Tripterygium Ingredients for Pathogenicity Cells in Rheumatoid Arthritis
by: Yujun Tang, et al.
Published: (2020-10-01)

Quantification of promoting efficiency and reducing toxicity of Traditional Chinese Medicine: A case study of the combination of Tripterygium wilfordii hook. f. and Lysimachia christinae hance in the treatment of lung cancer
by: Xiaoyi Zhang, et al.
Published: (2022-10-01)

Suppressive effects of the Chinese herbal remedy Tripterygium wilfordii Hook f on eosinophilia and IgE hyperproduction in mice
by: Kazuhito Asano, et al.
Published: (2000-01-01)

Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
by: Na Lin, et al.
Published: (2021-01-01)

Efficacy and safety of Tripterygium wilfordii polyglycosides for diabetic kidney disease: an overview of systematic reviews and meta-analyses
by: Ying Wang, et al.
Published: (2022-10-01)

Cloning and Characterisation of the Gene Encoding 3-Hydroxy-3-Methylglutaryl-CoA Synthase in Tripterygium wilfordii
by: Yu-Jia Liu, et al.
Published: (2014-11-01)

Mechanistic analysis for the origin of diverse diterpenes in Tripterygium wilfordii
by: Lichan Tu, et al.
Published: (2022-06-01)

Genome‐wide analysis of MYB family genes in Tripterygium wilfordii and their potential roles in terpenoid biosynthesis
by: Meng Xia, et al.
Published: (2022-07-01)

Synergetic HepG2 cells suppression efficacy of Tripterygium wilfordii and Scutellaria barbata through EGFR/PI3K/Akt pathway
by: Susu Liu, et al.
Published: (2022-09-01)

Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy
by: Shun-Lai Shang, et al.
Published: (2018-07-01)

Cloning, Expression Analysis and Functional Characterization of Squalene Synthase (SQS) from Tripterygium wilfordii
by: Bin Zhang, et al.
Published: (2018-01-01)

Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
by: Lin Wang, et al.
Published: (2021-06-01)

Metabolic profiling of fatty acids in Tripterygium wilfordii multiglucoside- and triptolide-induced liver-injured rats
by: Liu Xiaojie, et al.
Published: (2021-02-01)

Tripterygium wilfordii glycosides ameliorates collagen-induced arthritis and aberrant lipid metabolism in rats
by: Yitian Zhu, et al.
Published: (2022-08-01)